Navigation Links
Croissance Clinical Research Collaborates with Acceliant for Clinical Trial Excellence
Date:1/8/2014

BANGALORE, India, January 8, 2014 /PRNewswire/ --

Acceliant, a global technology provider of innovative clinical trial data management solutions, stated that Croissance Clinical Research, a full-fledged CRO providing services for pharmaceutical, bio-technology and medical devices companies, has preferred to choose Acceliant's eClinical Suite to aid their clinical trial data management. Acceliant's integrated e-PRO/EDC system offers a superior solution by allowing complete study data to be readily available and eliminating the integration costs.

     (Logo: http://photos.prnewswire.com/prnh/20130627/625230)

Satish Marukurthi, CEO, Croissance Clinical Research, said on this partnership, "Acceliant is our partner of choice based on their proven track record of accomplishments and expertise. We evaluated Acceliant eClinical Suite as being superior to other products in terms of driving efficiency and accelerating clinical trial studies. I believe that leveraging on Acceliant's knowledge and expertise will prove to be immensely beneficial for us in raising the standards of clinical trial efficiency."

Sri Manchala, CEO, Acceliant, commented, "Our integrated EDC-ePRO platform with innovative workflows and built-in mobility which allows data management from anywhere, anytime is designed to keep up with the everchangingever-changing needs of the life sciences industry. Our collaboration with Croissance Clinical Research strengthens our clientele and helps us differentiate ourselves in this highly competitive marketplace."

"Keeping up with our accelerated growth in India, we are proud to partner with Croissance Clinical Research.  We look forward to a successful long-term relationship aiding them in clinical trial management. This partnership strengthens our commitment to provide unparalleled services in the space of clinical trial management solutions," said Santhosh S. Nagaraj, Sales Head, Acceliant.

About Croissance Clinical Research

Croissance Clinical Research is a full service CRO, providing services to pharmaceutical, biotechnology and medical devices companies. At Croissance Clinical Research stalwarts of the Pharmaceutical and Clinical Research Industry have come together integrating their decades of knowledge and experiences to develop an optimized system for Clinical Research Industry. We apply our innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. Specialties include Clinical Trial Operations, Site Management, Clinical Data Management, Biostatistics, Medical Writing and Quality Assurance

About Acceliant

Acceliant is the medical industry technology division of Trianz, a global technology services and solutions company. A pioneer in the EDC industry, Acceliant has been providing solutions in the clinical trial management space since 1999. The company caters to the needs of the pharmaceutical, biotechnology, medical device, CRO, and non-profit drug research industries. Acceliant has helped facilitate clinical data management in hundreds of trials worldwide encompassing dozens of therapeutic areas for global giants as well as emerging healthcare innovators.

Prashant Bhavaraju
CMO
info@acceliant.com
+1-408-387-5899


'/>"/>
SOURCE Trianz
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MNX nomme un nouveau membre à son conseil dadministration, la société vise à accélérer sa croissance dans la logistique pour les domaines pharmaceutique et des essais cliniques
2. BioSpecifics Technologies Corp. Announces Positive Top-line Data from Phase 2 Clinical Trial of CCH for the Treatment of Human Lipoma
3. Data Sciences International acquires Buxco Research Company to expand preclinical research solutions offering
4. Clinical Trial Participation Today May Lead To Future Breakthroughs In Pancreatic Cancer, One Of The Nations Deadliest Cancers
5. TauRx Expands Alzheimers Clinical Trials in the United States
6. ideaPoint, Inc. Announces Launch of Multi-Sponsor Portal Providing Researchers Opportunity to Request Access to Clinical Data from Five Global Study Sponsors
7. Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
8. CMC Biologics and OncoSynergy Enter into Agreement to Develop and Manufacture Material for IND Enabling Studies and Phase I Clinical Trials
9. Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health
10. Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America
11. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
Breaking Medicine News(10 mins):